TORONTO, Dec. 12, 2016 /PRNewswire/ - Merus Labs International Inc. (“Merus” or the “Company”) [TSX: MSL, NASDAQ: MSLI] announced today that it will release its earnings for fiscal 2016 before the market opens on Wednesday, December 14, 2016 and hold a conference call at 8:30 am that same day to discuss the results.
The conference call can be accessed by dialing (888) 241-0551 and entering conference ID 38649327. International participants may dial (647) 427-3415. A replay of the call will be available for those not able to attend live by dialing (855) 859-2056.
About Merus Labs
Merus Labs is a specialty pharmaceutical company focused on acquiring and optimizing established and growth products. The Company leverages its expertise and commercial platform in Europe, Canada and select other markets to deliver value.
SOURCE Merus Labs Inc.
